114 related articles for article (PubMed ID: 7306915)
1. Phase I study of protracted venous infusion of 5-fluorouracil.
Lokich J; Bothe A; Fine N; Perri J
Cancer; 1981 Dec; 48(12):2565-8. PubMed ID: 7306915
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil and methotrexate administered simultaneously as a continuous infusion. A phase I study.
Lokich JJ; Phillips D; Green R; Paul S; Sonneborn H; Zipoli TE; Curt G
Cancer; 1985 Nov; 56(10):2395-8. PubMed ID: 4042072
[TBL] [Abstract][Full Text] [Related]
3. Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system.
Lokich J; Bothe A; Zipoli T; Green R; Sonneborn H; Paul S; Philips D
J Clin Oncol; 1983 Jan; 1(1):24-8. PubMed ID: 6668481
[TBL] [Abstract][Full Text] [Related]
4. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
Greenblatt MS; Mangalik A; Ferguson J; Elias L
Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
[TBL] [Abstract][Full Text] [Related]
5. A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers.
Ardalan B; Singh G; Silberman H
J Clin Oncol; 1988 Jun; 6(6):1053-8. PubMed ID: 3373260
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma.
Grem JL; McAtee N; Balis F; Murphy R; Venzon D; Kramer B; Goldspiel B; Begley M; Allegra CJ
Cancer; 1993 Aug; 72(3):663-8. PubMed ID: 8334622
[TBL] [Abstract][Full Text] [Related]
7. Combined 5-fluorouracil and floxuridine administered as a 14-day infusion. A phase I study.
Anderson N; Lokich J; Bern M; Wallach S; Moore C; Williams D; Umprayn V
Cancer; 1989 Mar; 63(5):825-7. PubMed ID: 2521571
[TBL] [Abstract][Full Text] [Related]
8. Protracted low-dose cisplatin infusion in advanced colorectal cancer.
Lokich J; Zipoli T; Greene R; Paul S; Sonnenborn H; Moore C
Cancer Treat Rep; 1986 Apr; 70(4):523-4. PubMed ID: 3698046
[TBL] [Abstract][Full Text] [Related]
9. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED
Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339
[TBL] [Abstract][Full Text] [Related]
10. 5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules.
John WJ; Neefe JR; Macdonald JS; Cantrell J; Smith M
Cancer; 1993 Dec; 72(11):3191-5. PubMed ID: 8242541
[TBL] [Abstract][Full Text] [Related]
11. A pilot trial of continuous infusion 5-fluorouracil with levamisole for adjuvant therapy of colon cancer.
Leichman CG; Poplin E; Zalupski M; Garcia Y; Grant A; Angeles A; DeJong L; Leichman L
J Infus Chemother; 1996; 6(2):84-6. PubMed ID: 8809655
[TBL] [Abstract][Full Text] [Related]
12. Protracted ambulatory venous infusion of 5-fluorouracil.
Lokich J; Fine N; Perri J; Bothe A
Am J Clin Oncol; 1983 Feb; 6(1):103-7. PubMed ID: 6837501
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of continuous infusion of 5-fluorouracil using an ambulatory pump for metastatic colorectal cancer.
Yamao T; Shimada Y; Kondo H; Shirao K; Yokota T; Sugano K; Saito D; Ohkura H; Yoshida S
Jpn J Clin Oncol; 1995 Apr; 25(2):46-50. PubMed ID: 7745822
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin C: phase I study of a constant infusion ambulatory treatment schedule.
Lokich J; Perri J; Fine N; Bothe A; Nelson T; Greene R; Zipoli T
Am J Clin Oncol; 1982 Aug; 5(4):443-7. PubMed ID: 7113965
[TBL] [Abstract][Full Text] [Related]
17. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.
Bertrand M; Doroshow JH; Multhauf P; Blayney DW; Carr BI; Cecchi G; Goldberg D; Leong L; Margolin K; Metter G
J Clin Oncol; 1986 Jul; 4(7):1058-61. PubMed ID: 3487626
[TBL] [Abstract][Full Text] [Related]
18. Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisons.
Anderson N; Lokich J
Cancer; 1992 Aug; 70(4 Suppl):998-1002. PubMed ID: 1638471
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide, methotrexate, and 5-fluorouracil in a three-drug admixture. Phase I trial of 14-day continuous ambulatory infusion.
Lokich J; Bern M; Anderson N; Wallach S; Moore C; Beauchamp K; Williams D
Cancer; 1989 Mar; 63(5):822-4. PubMed ID: 2914289
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of spirogermanium given daily.
Legha SS; Ajani JA; Bodey GP
J Clin Oncol; 1983 May; 1(5):331-6. PubMed ID: 6668504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
